欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/H/1211/001
药品名称Jamesi Novum
活性成分
    • Metformin hydrochloride 850.0 mg
    • Sitagliptin phosphate monohydrate 50.0 mg
剂型Film-coated tablet
上市许可持有人Zentiva k.s., U Kabelovny 130, Praha 102 37, Czech republic
参考成员国 - 产品名称Czechia (CZ)
Jamesi Novum
互认成员国 - 产品名称
    • Poland (PL)
    • Bulgaria (BG)
    • Slovakia (SK)
许可日期2024/07/03
最近更新日期2025/02/07
药物ATC编码
    • A10BD07 metformin and sitagliptin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase